Literature DB >> 6788680

Lack of evidence for IgM-induced ADCC: studies with monoclonal and polyclonal antibodies.

H Rumpold, G Wiedermann, O Scheiner, D Kraft, H Stemberger.   

Abstract

Different kinds of IgM antibodies were tested for their activity in antibody-dependent cellular cytotoxicity (ADCC): firstly an anti-benzylpenicilloyl (BPO) IgM antibody from immune rabbit serum purified by affinity, ion exchange, and molecular-sieving chromatography, secondly two monoclonal rat anti-BPO IgM antibodies and thirdly a human antidextran antibody prepared from a patient showing restriction of anti-dextran antibodies to the IgM class. Human lymphocytes or purified monocytes served as effector cells. While the two monoclonal rat and the human IgM antibodies showed no ADCC-mediating capacity, ADCC was induced by the rabbit anti-BPO IgM antibody when high antibody concentrations were used. This activity was abolished by further purification using an anti-rabbit IgG (Fc) immunosorbent. The initially observed activity was shown to be likely due to traces of aggregated anti-BPO IgG, which cannot be detected by the methods commonly used. Preincubation of lymphocytes for 24 hr increased the number of EA (IgM)] rosette forming cells but failed to induce IgM-mediated ADCC. Furthermore, evidence for amplification of low-dose IgG-ADCC by IgM could not be found.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6788680      PMCID: PMC1555199     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  23 in total

1.  Expression of a receptor for IgM by human T cells in vitro.

Authors:  L Moretta; M Ferrarini; M L Durante; M C Mingari
Journal:  Eur J Immunol       Date:  1975-08       Impact factor: 5.532

2.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

3.  The class of antibody involved in the antibody-dependent cell-mediated lysis of chicken erythrocytes.

Authors:  S Macphail
Journal:  Immunology       Date:  1976-11       Impact factor: 7.397

4.  Characterization of glass adherent human mononuclear cells.

Authors:  C A Koller; G W King; P E Hurtubise; A L Sagone; A F LoBuglio
Journal:  J Immunol       Date:  1973-11       Impact factor: 5.422

5.  Lymphocyte antibody lymphocytolytic interaction (LALI) with special emphasis on HL-A.

Authors:  G Trinchieri; M De Marchi; W Mayr; M Savi; R Ceppellini
Journal:  Transplant Proc       Date:  1973-12       Impact factor: 1.066

6.  [A quick and reliable method to recognize recent and older infections with rubella virus (author's transl)].

Authors:  W Frisch-Niggemeyer; F Heinz; H Stemberger
Journal:  Immun Infekt       Date:  1974-11

7.  Antibody in the sera of tumor-bearing mice that mediates spleen cell cytotoxicity toward the autologous tumor.

Authors:  P B Blair; M A Lane; P Mar
Journal:  J Immunol       Date:  1976-03       Impact factor: 5.422

8.  Benzylpenicilloyl specific serum antibodies to penicillin in man. I. Development of a sensitive hemagglutination assay method and haptenic specificities of antibodies.

Authors:  B B Levine; M J Fellner; V Levytska
Journal:  J Immunol       Date:  1966-04       Impact factor: 5.422

9.  Antibody-dependent lymphocyte cytotoxicity in the murine sarcoma virus system: activity of IgM and IgG with specificity for MLV determined antigen(s).

Authors:  E W Lamon; H M Skurzak; B Andersson; H D Whitten; E Klein
Journal:  J Immunol       Date:  1975-04       Impact factor: 5.422

10.  Influence of surface hapten density of sheep red blood cells on the hemolytic or blocking activity of IgG antibodies.

Authors:  G Wiedermann; M M Müller; O Förster; H Stemberger
Journal:  Int Arch Allergy Appl Immunol       Date:  1975
View more
  6 in total

1.  IgM response and resistance to ascites tumor growth.

Authors:  J L Subiza; J Coll; R Alvarez; M Valdivieso; E G de la Concha
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

2.  Antibody-dependent cell-mediated cytotoxicity. Effectors, signals, and mechanisms.

Authors:  E W Fuson; R A Hubbard; D G Sugantharaj; R B Andrews; M R Beard; R L Whittaker
Journal:  Surv Immunol Res       Date:  1983

3.  CD99 is a therapeutic target on disease stem cells in myeloid malignancies.

Authors:  Stephen S Chung; William S Eng; Wenhuo Hu; Mona Khalaj; Francine E Garrett-Bakelman; Montreh Tavakkoli; Ross L Levine; Martin Carroll; Virginia M Klimek; Ari M Melnick; Christopher Y Park
Journal:  Sci Transl Med       Date:  2017-01-25       Impact factor: 17.956

4.  Immunomodulation: Immunoglobulin Preparations Suppress Hyperinflammation in a COVID-19 Model via FcγRIIA and FcαRI.

Authors:  Fabian Bohländer; Dennis Riehl; Sabrina Weißmüller; Marcus Gutscher; Jörg Schüttrumpf; Stefanie Faust
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

5.  Anti-Gb3 monoclonal antibody inhibits angiogenesis and tumor development.

Authors:  Ariane Desselle; Tanguy Chaumette; Marie-Hélène Gaugler; Denis Cochonneau; Julien Fleurence; Nolwenn Dubois; Philippe Hulin; Jacques Aubry; Stéphane Birklé; François Paris
Journal:  PLoS One       Date:  2012-11-26       Impact factor: 3.240

6.  The Functional Role of IgA in the IgM/IgA-Enriched Immunoglobulin Preparation Trimodulin.

Authors:  Fabian Bohländer; Sabrina Weißmüller; Dennis Riehl; Marcus Gutscher; Jörg Schüttrumpf; Stefanie Faust
Journal:  Biomedicines       Date:  2021-12-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.